EP 0377657 A1 19900718 - HUMAN OVARIAN TUMOR-ASSOCIATED ANTIGEN SPECIFIC FOR MONOCLONAL ANTIBODY OV-TL3.
Title (en)
HUMAN OVARIAN TUMOR-ASSOCIATED ANTIGEN SPECIFIC FOR MONOCLONAL ANTIBODY OV-TL3.
Title (de)
MENSCHLICHES OVARIALTUMOR ASSOZIERTES ANTIGEN, DAS SPEZIFISCH IST FÜR DEN ANTIKÖRPER OV-TL3.
Title (fr)
ANTIGENE ASSOCIE A DES TUMEURS DES OVAIRES HUMAINS SPECIFIQUE DE L'ANTICORPS MONOCLONAL OV-TL3.
Publication
Application
Priority
US 8716487 A 19870819
Abstract (en)
[origin: WO8901629A1] An antigen associated with ovarian carcinoma is described. The antigen is expressed by ovarian carcinoma of the serous, mucinous, endometrioid and clear cell types. Methods of diagnosis and therapy of ovarian carcinoma based upon the discovery and characterization of the antigen are also described.
Abstract (fr)
Un antigène associé au carcinome ovarien est exprimé par des carcinomes ovariens des types séreux, mucineux, endométrioïde et à cellules claires. L'invention concerne également des procédés de diagnose et de thérapie de carcinomes ovariens fondés sur le découverte et la caractérisation de l'antigène.
IPC 1-7
IPC 8 full level
G01N 33/574 (2006.01); A61K 39/00 (2006.01); A61K 39/395 (2006.01); A61K 45/00 (2006.01); A61K 47/48 (2006.01); A61K 51/00 (2006.01); A61K 51/10 (2006.01); C07K 14/435 (2006.01); C07K 14/705 (2006.01); C07K 16/30 (2006.01); C07K 19/00 (2006.01); C12N 5/10 (2006.01); C12N 15/02 (2006.01); C12P 21/08 (2006.01); G01N 33/577 (2006.01); A61K 38/00 (2006.01); C12R 1/91 (2006.01)
CPC (source: EP US)
A61K 39/0011 (2013.01 - EP US); A61K 47/6869 (2017.08 - EP); A61K 51/1072 (2013.01 - EP); C07K 16/30 (2013.01 - EP); A61K 38/00 (2013.01 - EP); A61K 2123/00 (2013.01 - EP)
Designated contracting state (EPC)
AT BE CH DE FR GB IT LI LU NL SE
DOCDB simple family (publication)
WO 8901629 A1 19890223; EP 0377657 A1 19900718; JP H02504517 A 19901220
DOCDB simple family (application)
US 8802831 W 19880818; EP 88908515 A 19880818; JP 50791088 A 19880818